Home » Discovery Biology Pharmaceutical Services » In Vitro Pharmacology » GPCR Target Solutions » Radioligand Receptor Binding Assays
Radioligand binding assay methods are preferred to study the binding properties of test compounds in drug discovery, such GPCRs and ion channels. However, the regulatory requirements, high construction and maintenance costs prohibit most of labs from utilizing an exclusive radioisotope-based assay platform.
To address the problem, GenScript has constructed a powerful radioisotope-based assay platform as a low cost solution for your project. Based on the platform, scintillation proximity assay (SPA) and filtration binding assay are available tailored to your specifications. In addition, GenScript has validated many GPCR binding assays and hERG binding assay for your immediate screening.
Related Services and Products